Jean-michel M. Scherrmann

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studies.

Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studies.

Journal: Toxicology and applied pharmacology

Published: October 25, 2022

Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 Spread.

Epidemiokinetic Tools to Monitor Lockdown Efficacy and Estimate the Duration Adequate to Control SARS-CoV-2 Spread.

Journal: Journal of epidemiology and global health

Published: May 22, 2021

Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses.

Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses.

Journal: Journal of general internal medicine

Published: April 18, 2021

Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

Journal: Handbook of experimental pharmacology

Published: January 21, 2021

Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.

Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.

Journal: The Journal of antimicrobial chemotherapy

Published: August 09, 2020

Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools.

Is Lockdown Effective in Limiting SARS-CoV-2 Epidemic Progression?-a Cross-Country Comparative Evaluation Using Epidemiokinetic Tools.

Journal: Journal of general internal medicine

Published: August 03, 2020

Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy.

Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy.

Journal: Clinical pharmacology and therapeutics

Published: May 25, 2020

Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

Journal: Journal of clinical pharmacology

Published: April 21, 2020

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.

Journal: The AAPS journal

Published: April 17, 2020

ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.

ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.

Journal: Pharmaceutics

Published: November 14, 2019

LC-MS/MS-based quantification of efflux transporter proteins at the BBB.

LC-MS/MS-based quantification of efflux transporter proteins at the BBB.

Journal: Journal of pharmaceutical and biomedical analysis

Published: March 26, 2018

Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity.

Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 06, 2017

Showing 1-12 of 53

Last Updated: 09/26/2026